Schedule 13G ownership disclosure
Epizyme, Inc.
Security class unavailable · CUSIP: 29428V104
Event date: 2022-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,598,934
- Percent of class
- 9.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-22-002908
- Form type
- SC 13G
- Filer
- Epizyme, Inc.
- CIK
- CIK 1571498
- Filed
- Aug 09, 2022
- Reporting period
- Jul 31, 2022
- Description
- Schedule 13G beneficial ownership